AUCTORES
Globalize your Research
Research Article | DOI: https://doi.org/10.31579/2641-0419/118
*Corresponding Author: Ella Yahud, Assuta Ashdod University Hospital 7747629 Ha-Refua St 7, Ashdod, Israel
Citation: Ella Yahud., Avishag Laish-Farkash., Nir Shlomo., Noam Fink., Ilan Goldenberg, Eli Lev., Elad Asher., (2021) Temporal Trends in Prognosis of Patients with Acute Coronary Syndrome Complicated by Ventricular Tachyarrhythmia. J. Clinical Cardiology and Cardiovascular Interventions, 4(3); Doi:10.31579/2641-0419/118
Copyright: © 2021 Ella Yahud, This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Received: 07 December 2020 | Accepted: 26 January 2021 | Published: 11 February 2021
Keywords: ventricular tachyarrhythmia; all-cause mortality; acute coronary syndrome; NSTEMI; STEMI; risk-factors.
Objectives: To evaluate clinical characteristics and prognosis of patients presented with ventricular tachyarrhythmia (VTA) during the course of acute coronary syndrome (ACS) and to analyze it according to period of presentation.
Background: VTA is an infrequent yet serious complication of ACS. There is limited data regarding the incidence and prognostic implications of VTA in the last decade as compared with the previous decade.
Methods: We evaluated clinical characteristics, major adverse cardiovascular events, short and long- term mortality of patients hospitalized with ACS who were enrolled in the Acute Coronary Syndrome Israeli Survey (ACSIS) during the years 2000-2016. Patients were classified into three groups: no VTA, early VTA (≤48h of onset) and late VTA (>48h of onset). Data were analyzed according to decades of presentation (current decade vs. previous decade).
Results: The study population comprised 15,200 patients. VTA occurred in 487 (3.2%) of patients. Early VTA presented in 373/487 (77%) patients and late VTA in 114/487 (23%) patients. VTA’s, occurring in ACS patients were associated with increased risk of in-hospital, 30-days, 1-year and 5-year mortality rates during both early and late periods in compared with no VTA. Moreover, late VTA was associated with the highest mortality rate with up to 65% in 5-year follow up (p<0.001). Nevertheless, late VTA was associated with lower mortality rate in the current decade (2008-2016) compared with last decade (2000-2006).
Conclusions: Any VTA following ACS was associated with high short and long-term mortality rate. Howevr, over the past decade there has been a significant improvement in survival rates, especially in patients with late VTA. This may be attributed to early and invasive reperfusion therapy, implantable cardioverter defibrillator implantation and better medical treatment.
Ventricular tachyarrhythmia (VTA) especially sustained ventricular tachycardia and ventricular fibrillation, is an infrequent yet serious complication of acute coronary syndrome (ACS). Prior studies reported that VTA complicates 2-8% of ACS cases and has adverse implications on in-hospital and long-term mortality [1, 2]. Early VTAs occur in the first 48 hours of acute myocardial infarction (AMI) and are the most frequent cause of AMI-related death [3]. Late VTAs i.e. > 48 hours of AMI onset are usually associated with ventricular dysfunction [4]. Over the past decade, major advances in the treatment of patients with AMI have occurred and led to improved survival [5]. Currently, however, there is limited data regarding the incidence and temporal trends over recent years in the outcomes of patients presenting with VTA complicating ACS. Moreover, limited information exists regarding the association between VTA observed during ACS hospitalization to short and long-term mortality. This is despite overall enhanced therapy and improved survival among ACS patients. Therefore, the purpose of the current study was to evaluated temporal trends of clinical characteristics and outcomes over the last two decades (2000-2016) among ACS patients presenting with and without VTA who were enrolled in the Acute Coronary Syndrome Israeli Survey (ACSIS) survey.
The present study is a cohort data analysis of patients who were enrolled prospectively in the ACSIS from 2000 to 2016. Details of ACSIS have been previously reported [6]. In brief, this survey is conducted biennially over a 2-month period among ACS patients admitted to coronary care units and cardiology wards in all 27 public hospitals in Israel.
Patient management was at the discretion of the attending physicians. The diagnosis of AMI and ST-segment elevation MI (STEMI) or non- ST-segment elevation MI (NSTEMI), was made by the attending cardiologist according to pre-specified survey criteria based on accepted guidelines. In total 15,200 patients were enrolled in our study. The patients were grouped according to the occurrence of ventricular arrhythmias during the course of index AMI. Data included baseline demographics, medical history, hospital course, procedures, complications, and outcome based on hospital’s charts. Additional data regarding health status, adverse events and medication adherence were collected from the patients via follow-up calls and from outpatients’ medical records one month after hospital discharge. Mortality rates were determined for all patients from hospital and out-patient charts and by matching their identification numbers with the Israeli National Population Register. In- hospital, one year, and five-year all-cause mortality was assessed for the absence of VTA, early VTA and late VTA according to the periods of presentation.
The diagnosis of VTA, sustained ventricular tachycardia or ventricular fibrillation was based on electrocardiogram (ECG) or continuous monitor strips. Sustained ventricular tachycardia was defined as a series of abnormally shaped QRS complexes longer than 120 milliseconds, with a rate 100-250 beats/minute, lasting longer than 30 seconds or requiring electrical cardioversion due to hemodynamic collapse. Ventricular fibrillation was defined as rapid, very irregular rhythm with indiscernible P waves or QRS. Patients were classified into three groups: no VTA; early VTA (≤48h of onset) and late VTA (>48h of onset). Survey periods were divided to early decade (2000-2006) vs. late decade (2008-2016). Primary endpoints were 30-day, 1-year and 5-year mortality rate. Secondary endpoints included 30-day major adverse cardiac events (MACE) (all-cause mortality rate, re-infarction, stent thrombosis and urgent revascularization). Left ventricular ejection fraction (LVEF) was graded according to echocardiography performed at admission in each center.
Demographic, clinical features and the use of in-hospital therapies were reported for all study participants. Multiple logistic regression adjustments for age, gender, diabetes mellitus, chronic renal failure and heart failure and for survey periods was performed to assess the adjusted odds ratio (OR) and 95% confidence interval (CI) of in and out of hospital complications and 30-day, 1 and 5-year mortality rate associated with VTA at any time during and after the admission for ACS. The cumulative probability of all-cause mortality rate was graphically displayed using the Kaplan–Meier method and compared using the log-rank test. In order to evaluate the independent association of VTA with the 5-year all-cause mortality rate outcome, a Cox proportional hazards model was constructed adjusting for survey period. We employed an interaction-term analysis to examine whether the risk of 5-year mortality rate associated with VTA was different in the early period as compared with the late period. Statistical significance was accepted for a 2-sided p<0.05. Statistical analysis was performed using the R Statistical Package (R Foundation for Statistical Computing, Vienna, Austria).
Baseline characteristics
The study population comprised of 15,200 patients with ACS. Of them 11682 (77%) were males, 5383 (35%) suffered from diabetes mellitus 8894 (59%) had a history of arterial hypertension, 9757 (64%) had dyslipidemia and 6931 (46%) presented with STEMI. Patient's baseline characteristics are presented in Table 1.
Table 1: Baseline characteristics by VTA presence
Ventricular tachyarrhythmia characteristics
Four hundred eighty seven patients (3.2 %) had VTA during their hospitalization. Among those patients, 373/487 (77%) had early VTA and 114/487 (23%) had late VTA. The incidence of both types of VTA's remained the same in the past 15 years as shown in Figure 1.
Patients with late VTA were older (65±14 vs. 64±13, p<0.001) and had significantly higher incidence of co-morbidities and coronary risk factors such as diabetes mellitus, arterial hypertension, as well as known coronary artery disease, and chronic renal failure as shown in Table 1.
Outcome
Rate of MACE was higher in late VTA then in early and non-VTA (49% vs. 23% vs. 8%, respectively, p<0.001). As shown with logistic regression model the presence of late VTA was associated with three folds’ higher ratios for 30 days MACE (p<0.001), Figure 2.
In- hospital and 1-year mortality rate were also higher in the presence of late VTA as compared with no VTA [HR 27.44 (95% CI 17.56- 42.49) and 9.78 (95% CI 6.57- 11.18), respectively, p<0.001]. Even after multivariate logistic regression for confounders the presence of early VTA and late VTA, were independently associated with increased risk of in-hospital mortality rate [OR 9.65 (95% CI 7.0-13.13) and 27.64 (95% CI 17.56-42.49), respectively, p<0.001], and early post- discharge mortality rate [OR 8.75 (95% CI 5.98-12.24) and 22.6 (95% CI 14.5-35.62), respectively, p<0.001]. Moreover, multivariable Cox proportional hazard analysis including baseline potential confounders confirmed that 5-year mortality rate was also higher in late VTA then in early and non-VTA (HR 8.27 vs. 2.65, for late and early VTA, respectively 95% CI 2.05-3.42).
Late vs. Early period
The 1 and 5-year all-cause mortality rate was lower during the late period as compared with the early period for patients with no VTA, early VTA and late VTA (8% vs 10%, 20% vs 25% and 37% vs 65%, all log-rank p <0.001, respectively for 1 year) and (20% vs 23%, 26% vs 29% and 45% vs 75%, all log-rank p <0.001, respectively for 5 years) as shown in Figure 3 and 4. Moreover, the late period was associated with lower all-cause mortality rates for in-hospital, 1 year and 5 years mortality rate (OR 0.56, 0.66 and 0.82, p<0.001, respectively).
In the early period ICD was implanted during hospitalization in 15 (0.2%) patients with no VTA, 3 (1.4%) patients with early VTA and 5 (8%) with late VTA (p<0.001). In the late period in hospital implantation of ICD was performed in 25 (0.4%), 8 (5%) and 0 patients, respectively (p<0.001).
In our study during early period chronic treatment with beta blockers was administered to 34%, 24% and 42.5% of patients with no VTA, early VTA and late VTA respectively, p= 0.018; beta blockers at discharge were prescribed to 78%, 72% and 51% of patients respectively, p<0.001
During the late period 38.5%, 35% and 42% of patients with no VTA, early VTA and late VTA, respectively, used beta blockers chronically, p=0.6 and 80.5%, 81.5%, 73% of patients, respectively, were discharged with beta blockers, p=0.4 Chronic angiotensin-converting-enzyme inhibitor (ACEI) treatment in early period was used in 26%, 31% and 22% of patients with no VTA, early VTA and late VTA p=0.8; ACEI after discharge were prescribed to 61%, 61.5% and 57%, respectively, p=0.9
During the late period chronic ACEI treatment was administered to 32%, 32%, 24% of patients with no VTA, early VTA and late VTA respectively, p=0.08; ACEI in discharge were prescribed to 67%, 66%, 47% of patients respectively, p=0.018
In the current study, VTA occurred in roughly 3% of ACS patients admitted to the hospital with the majority (77%) of those arrhythmias occurred during the first 48 hours of ACS. Moreover, the incidence of both early and late VTA did not change significantly during the years 2000-2016, suggesting it was not related to medical treatment.
Previous data on prognostic significance of VTA is controversial. In the HORIZONS-AMI Trial [7] there was no significant difference in MACE and 3-year mortality rate in patients with or without VTA that occurred after primary percutaneous coronary intervention (PCI). Another recent study, found that in patients with STEMI that survived out of hospital cardiac arrest due to VTA and underwent primary PCI, the 1-year mortality was equal to those without out of hospital cardiac arrest [8]. On the other hand, in the MILIS study [9] the in hospital mortality rate was significantly increased by VTA, especially late VTA, causing cardiac arrest during ACS hospitalization, although there was no difference in mortality rate in the 32-month follow up as compared with patients with no VTA. In APEX AMI trial [10], pre and post primary PCI VTA were also shown to be associated with significantly increased 90 days mortality. Piccini et al. [11] studied a large population of 9000 patients with STEMI and NSTEMI undergoing PCI. In their study, the rate of early VTA was 5.2% and it was also related to increase mortality risk by 4.4 folds as compared with no VTA. Our data is in accord to the aforementioned trials suggesting that VTA occurrence during the course of ACS is not benign. Short and long-term mortality rate was increased dramatically by the presence of early and especially late VTA as compared with no VTA. This was consistent even after adjustment for multiple confounders. In the logistic regression analysis model the presence of late VTA wass associated with 27 folds’ increase of in hospital mortality, 10 folds increased one-year mortality and 8 folds increased 5 years mortality rate. The proposed reason why late VTA carries an increased risk of death might be its association with pump failure and hemodynamic deterioration rather than arrhythmic death [12, 13].
Interestingly, although the overall prognosis of ACS patients improved in the last decade [14] as well as in our study, the most prominent improvement in our study was seen in those who had late VTA, as shown in Figures 3 and 4. Wider use of ACE inhibitors and beta blockers at discharge in the late VTA group, early reperfusion strategy, [15, 16], as well as wider use of implantable and wearable cardioverter defibrillators could explain our findings.
Limitations
Due to its observational non-randomized design, the current study is subject to limitations as described in detail previously [17]. Thus, despite efforts to control for confounding factors by applying multivariate analysis, we cannot exclude unmeasured factors, which could have biased the results. Moreover, data regarding 5 years survival rate is limited in the late period with no long term data since the year 2016. Nevertheless, in spite of these limitations, the study in a multicenter nationwide survey with large study population and long term outcomes.
Conclusions
In summary, in this national, multicenter, contemporary “real life” setting, we did not observe any change in the rate of VTA. Nevertheless, any VTA following AMI was associated with high short and long-term mortality rate. However, over the past decade there has been a significant improvement in survival rates, especially in patients with late VTA that may be attributed to early and invasive reperfusion therapy, implantable cardioverter defibrillator implantation and better medical treatment.
No conflict of interest and no relationship with industry exists
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
